Common early-life exposure of the colorectal epithelium to the microbiome-derived mutagen colibactin

Colibactin is a mutagen produced by bacterial strains in the colorectal microbiomes of some healthy people. It generates somatic mutations characterised by the mutational signatures SBS88 and ID18 in normal human colorectal epithelial cells in vivo. Increasing prevalence of colibactin mutagenesis during the 20th century is hypothesised to have caused recent international increases in early-onset colorectal cancer incidence. Here, we establish the early-life prevalence, timing, mutation burdens and distribution through the colon of colibactin mutagenesis by sequencing normal colorectal epithelial cell genomes to detect SBS88 and ID18 in 90 healthy and inflammatory bowel disease affected children and adolescents. Colibactin-induced mutagenesis was present in ~43%, with or without inflammatory bowel disease. It usually begins shortly after birth and ceases by age five years. Mutation burdens are higher in the left than right colon and show substantial variation, with some children displaying mutation burdens comparable to those of healthy non-exposed individuals greater than 60 years of age. The future public health implications of this common early life mutagen exposure will depend on clarification of its role in colorectal cancer causation.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.766949
Primary Topic
Genetic factors in colorectal cancer
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Common early-life exposure of the colorectal epithelium to the microbiome-derived mutagen colibactin

Paul Brennan, Claire Glemas, Johan M. Burisch, Nicolas Wyvekens et al.
6 links
bioRxiv (Cold Spring Harbor Laboratory)
Genetic factors in colorectal cancer
preprint

Common early-life exposure of the colorectal epithelium to the microbiome-derived mutagen colibactin

Paul Brennan, Claire Glemas, Johan M. Burisch, Nicolas Wyvekens, Laura Humphreys, Kelly Spike, Matthias Zilbauer, Raheleh Rahbari, Yan Shao, Maria Dorn‐Rasmussen, My H. Pham, Henry N. Marshall, Trevor D. Lawley, Will Knight, Ammal Abbasi, Vibeke Wewer, Stephen F. Fitzgerald, Anh Phuong Le, Michael R. Stratton, Tim H. H. Coorens, Komal Nayak, Ievgeniia Chicherova, Yichen Wang, Yvette E. Hooks, Ludmil B. Alexandrov, Rashesh Sanghvi, Andrew Ramos, Calli Latimer, Sarah Moody, Inigo Martincorena, Soyeon Kim, Peter Campbell, Jiali Pang, Rob Heuschkel, Hyunchul Jung
preprint en

Abstract

Colibactin is a mutagen produced by bacterial strains in the colorectal microbiomes of some healthy people. It generates somatic mutations characterised by the mutational signatures SBS88 and ID18 in normal human colorectal epithelial cells in vivo. Increasing prevalence of colibactin mutagenesis during the 20th century is hypothesised to have caused recent international increases in early-onset colorectal cancer incidence. Here, we establish the early-life prevalence, timing, mutation burdens and distribution through the colon of colibactin mutagenesis by sequencing normal colorectal epithelial cell genomes to detect SBS88 and ID18 in 90 healthy and inflammatory bowel disease affected children and adolescents. Colibactin-induced mutagenesis was present in ~43%, with or without inflammatory bowel disease. It usually begins shortly after birth and ceases by age five years. Mutation burdens are higher in the left than right colon and show substantial variation, with some children displaying mutation burdens comparable to those of healthy non-exposed individuals greater than 60 years of age. The future public health implications of this common early life mutagen exposure will depend on clarification of its role in colorectal cancer causation.

bioRxiv (Cold Spring Harbor Laboratory)
Broad Institute (US), European Bioinformatics Institute (GB), Wellcome/MRC Cambridge Stem Cell Institute (GB), University of Cambridge (GB), Amager Hospital (DK), Hvidovre Hospital (DK), Cambridge University Hospitals NHS Foundation Trust (GB), Wellcome Sanger Institute (GB), Copenhagen University Hospital (DK), University of California San Diego (US), Bridge University (SS), Centre international de recherche sur le cancer (FR)
Wellcome Trust, Novo Nordisk, HORIZON EUROPE Framework Programme
Good health and well-being
Genetic factors in colorectal cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon